BUR3 and BUR6 were identified previously by selecting for mutations that increase transcription from an upstream activating sequence (UAS)-less promoter in Saccharomyces cerevisiae. The bur3-1 and bur6-1 mutations are recessive, increase transcription from a suc2⌬uas allele, and cause other mutant phenotypes, suggesting that Bur3p and Bur6p function as general repressors of the basal transcriptional machinery. The molecular cloning and characterization of BUR3 and BUR6 are presented here. BUR3 is identical to MOT1, a previously characterized essential gene that encodes an ATP-dependent inhibitor of the TATA box-binding protein. Cloning and nucleotide sequence analysis reveals that BUR6 encodes a homolog of DRAP1 (also called NC2␣), a mammalian repressor of basal transcription. Strains that contain a bur6 null allele are viable but grow extremely poorly, demonstrating that BUR6 is critical for normal cell growth in yeast. The Bur6p histone fold domain is required for function; an extensive nonoverlapping set of deletion alleles throughout the histone fold domain impairs BUR6 function in vivo, whereas mutations in the amino-and carboxy-terminal tails have no detectable effect. BUR6 and BUR3/MOT1 have different functions depending on promoter context: although the bur3-1 and bur6-1 mutations increase transcription from ⌬uas promoters, they result in reduced transcription from the wild-type GAL1 and GAL10 promoters. This transcriptional defect is due to the inability of the GAL10 UAS to function in bur6-1 strains. The similar phenotypes of bur6 and bur3 (mot1) mutations suggest that Bur6p and Mot1p have related, but not identical, functions in modulating the activity of the general transcription machinery in vivo.
Basal transcription of most, if not all, protein-encoding genes requires the activity of RNA polymerase II and the general transcription factors (GTFs) TFIIA, TFIIB, TFIID, TFIIE, TFIIF, and TFIIH (66) . Highly purified preparations of RNA polymerase II and the GTFs are both necessary and sufficient to direct promoter-specific basal transcription at the correct initiation sites on a number of model templates in vitro. The levels of transcription that are established by this basal machinery are then regulated either positively or negatively in a promoter-specific manner mediated through cis-acting regulatory elements. The mechanism by which regulatory factors influence the activities of the GTFs remains an area of intense interest, because transcription initiation is usually the major regulatory step in differential gene expression and thus performs critical roles in normal cell growth and in the development and differentiation of multicellular organisms.
Regulators of the general transcription machinery can be grouped into two main classes. The best-characterized class of regulators contains the site-specific DNA-binding proteins that recognize cis-acting regulatory elements known as upstream activating sequences (UASs) in Saccharomyces cerevisiae or enhancers in larger eukaryotes (40, 55) . A second class of transcriptional regulators affects the general transcription machinery in a UAS-independent manner. UAS-less promoters are transcribed by RNA polymerase II and the GTFs in vitro yet are often transcribed very poorly, if at all, in vivo. The identification of recessive mutations that increase transcription from UAS-less promoters in the yeast S. cerevisiae (7, 11, 13, 28, 36, 43, 47) indicates that basal promoter elements are capable of higher levels of transcription in vivo but are normally repressed in wild-type strains. A number of recent studies have begun to identify at least two classes of proteins that repress the GTFs by distinctly different mechanisms in vivo.
One class of general transcriptional repression activity in vivo is due to the assembly of the DNA template into nucleosomes (20) . Nucleosomes inhibit the recognition of regulatory elements by some UAS-binding proteins (45, 58) , thereby reducing activated transcription, but nucleosomes can also affect basal transcription by inhibiting the function of GTFs (33, 64) . For example, assembly of the adenovirus major late promoter into nucleosomes represses transcription in vitro but not if the template is incubated with TFIID prior to assembly (64) . This result suggests that nucleosomes inhibit binding of TFIID to the TATA box. Recent studies utilizing purified recombinant TATA-binding protein (TBP) demonstrated that nucleosomes directly inhibit binding of TBP, confirming and extending the results obtained with the crude TFIID fraction (24) . The inhibitory effects of nucleosomes on basal transcription have also been demonstrated in vivo; depletion of nucleosomes in yeast results in increased constitutive expression from the PHO5, CYC1, GAL1, CUP1, and HIS3 basal promoters fused to lacZ (15, 21) . Furthermore, mutations in the genes encoding histones H2A and H2B alter transcription from promoters that contain insertions of Ty elements (Spt Ϫ phenotype) and increase transcription from a suc2⌬uas promoter (9, 22) . Nucleosomal repression is likely to require more factors than just the core histones, and genetic selections in yeast have identified additional factors that are likely to inhibit transcription through chromatin effects (8, 48, 54, 62) .
Another class of repressors directly inhibits the activity of the GTFs in a chromatin-independent manner. Proteins such as Mot1, Dr1 (also called NC2), and NC1 (2, 25, 37) were all identified as having biochemical activities that inhibit the function of the TBP subunit of TFIID in vitro. Mot1p displaces TBP from the TATA box in an ATP-dependent manner (2), while NC1 and Dr1/NC2 allow TBP to bind DNA but inhibit subsequent interactions between TBP and TFIIA and/or TFIIB (25, 32) . The in vivo role of each of these TBP inhibitors is not yet clear, but the phenotype of mot1 mutations is consistent with its proposed repressor activity, since mot1 mutations cause increased transcription from ⌬UAS promoters in vivo (13) . An important issue raised by these studies is whether analogous activities that specifically inhibit other components of the basal transcription machinery exist.
We have used a genetic selection designed to identify mutations that affect basal transcription in S. cerevisiae (47) , with the expectation that such mutations would identify additional chromatin-dependent and chromatin-independent repressors of the basal machinery. The promoter used for this selection was the suc2⌬uas(-1900/-390) allele (51), which produces barely detectable levels of transcripts, thus causing an inability to grow on media that contain sucrose as the carbon source (Suc Ϫ phenotype). A selection for Suc ϩ suppressors of suc2⌬uas(-1900/-390) identified many mutations in previously characterized SPT genes, including those that encode histones H2A and H2B. However, six other genes were also identified by this selection and were designated BUR1 through BUR6 (for bypass UAS requirement) (47) . In addition to suppressing suc2⌬uas, each of the bur mutations causes other mutant phenotypes, indicating that they have more general effects and also that they are likely to affect expression from some wild-type promoters. Further evidence that the BUR gene products have important general roles in transcription is provided by the ability of some bur mutations to suppress transcriptional defects caused by an snf5 mutation (47) . Snf5p is a component of the highly conserved SNF-SWI complex, which is required for transcription at many diversely regulated promoters in vivo (42, 44) . Genetic and biochemical evidence indicates that the SNF-SWI complex helps TBP and site-specific activators bind to nucleosomal DNA (12, 23, 24, 34) . Based on their distinct sets of unselected mutant phenotypes, including the ability to suppress snf5 mutations, it was proposed (47) that the bur mutations comprise two groups that suppress suc2⌬uas by different mechanisms. One group contains BUR1, BUR2, BUR4, and BUR5, while the other group consists of BUR3 and BUR6. Since BUR5 encodes histone H3 (47) , the first group of BUR genes was proposed to suppress suc2⌬uas via nucleosomal repression while the second group was proposed to suppress suc2⌬uas by a nucleosome-independent mechanism, perhaps by directly repressing the basal transcription factors. The results presented here support this hypothesis: BUR3 is identical to MOT1 (13) , which encodes an inhibitor of the TBP, while BUR6 encodes a histone fold-containing protein with significant sequence similarity to the mammalian repressor DRAP1 (also called NC2␣). Surprisingly, analysis of transcriptional defects in bur3-1 and bur6-1 mutant strains suggests that MOT1 and BUR6 may also have positive roles at some promoters in vivo.
MATERIALS AND METHODS
Media and genetic methods. S. cerevisiae strains used in this study are shown in Table 1 . All strains used in this study were derived from FY2 (MAT␣ ura3-52), a GAL2 ϩ derivative of S288C (63) . All media used, including rich medium (YPD), synthetic complete drop-put medium (for example, SC-Ura), minimal medium (SD), and sporulation medium, were made as described previously (50) . YPSuc plates contained YEP, 2% sucrose, and 1 g of antimycin A (Sigma) per ml. YPGal plates contained YEP, 2% galactose, and 1 g of antimycin A per ml. Standard genetic methods for mating, sporulation, and tetrad analysis (50) were used throughout this study. Yeast cells were transformed by the lithium acetate method (27) .
Plasmids. pGP256, the original BUR6 ϩ plasmid that was isolated from a YCp50-based yeast genomic DNA library (49) , contains a 20,007-bp Sau3A insert at the BamHI site of YCp50. A 2,393-bp BglII fragment that contains BUR6 was subcloned from pGP256 into the BamHI site of pRS416 to create pGP258. To construct a bur6 null allele, an 820-bp EcoRI-StuI fragment of TRP1 was used to replace the NdeI-KpnI fragment of BUR6, generating the bur6⌬2::TRP1 null allele in pGP267. To integrate this null allele at the BUR6 genomic locus, a 2.4-kb BglII fragment of pGP267 containing bur6⌬2::TRP1 was transformed into the diploid strain GY139 and Trp ϩ transformants were selected. Integration at the BUR6 locus was confirmed by Southern blotting. The same 2.4-kb BglII fragment was also cloned into the BamHI site of pRS416 to create pGP273. Plasmids containing the ho⌬uas-lacZ reporter (p740), HO-lacZ (p1701), and the cyc1⌬uas-lacZ reporter (pLG⌬Ϫ178) were obtained from David Stillman, while the GAL10 UAS -CYC1p-lacZ (pLGSD5) and GAL4 BSCYC1p-lacZ (pSV14) plasmids were obtained from Karen Arndt.
RNA analysis. Cells were grown to 1 ϫ 10 7 to 2 ϫ 10 7 cells per ml, and RNA was isolated as described previously (6) . RNA was separated in a 1% formaldehyde agarose gel. Blotting and hybridization to DNA probes were performed as described previously (56) . The probes used were pDE32-1 (SPT15) and an ϳ1.8-kb EcoRI fragment from p4812 (GAL1 and GAL10). RNA was crosslinked to GeneScreen (New England Nuclear) with the auto cross-link mode in a Stratalinker 1800 (Stratagene). Probes were radiolabeled with 32 P with a random priming kit from Boehringer Mannheim according to the manufacturer's directions.
␤-Galactosidase assays. Five-milliliter yeast cultures were grown to a density of 1 ϫ 10 7 to 2 ϫ 10 7 cells per ml in SC-Ura medium to select for reporter plasmids. Cells were harvested by centrifugation and were resuspended in 250 l of breaking buffer (0.1 M Tris [pH 8.0], 20% glycerol, 1 mM dithiothreitol, 1 mM phenylmethylsulfonyl fluoride). Cells were disrupted by vortexing six times for 1 min at 4ЊC in the presence of an equal volume of glass beads. More breaking buffer (250 l) was added, the tubes were vortexed again briefly, and the liquid was transferred to a 1.5-ml tube and centrifuged for 15 min at 4ЊC to remove cellular debris. The supernatants were assayed for ␤-galactosidase activity as described previously (39) . Protein levels were determined by the method of Bradford (5a) with bovine serum albumin as the protein standard. All reported ␤-galactosidase levels are the means from at least three independent transformants with standard errors of Ͻ20%.
Construction of bur6 deletion alleles. Deletion alleles of bur6 were created by oligonucleotide-directed mutagenesis of plasmid pGP258. pGP258 contains BUR6 on a 2.4-kb BglII fragment cloned into the BamHI site of pRS416. pGP258 was transformed into the dut1 ung1 mutant Escherichia coli strain RZ1032, and single-stranded DNA was prepared after infection with the M13 helper phage K07. The single-stranded DNA was mutagenized with a Mut-a-gene kit from Bio-Rad Laboratories according to the manufacturer's directions. All deletion mutations were verified by DNA sequencing of the entire BUR6 open reading frame.
Western analysis. Cells were grown to mid-log phase in 10 ml of dropout medium, harvested, and lysed by vortexing in the presence of glass beads in a buffer that contained 50 mM Tris (pH 7.5), 150 mM NaCl, 10 mM MgCl 2 , 1 mM EDTA, 1 mM dithiothreitol, 1 mM phenylmethylsulfonyl fluoride, 10% glycerol, 200 g of aprotinin per ml, 100 g of peptstatin A per ml, and 50 g of leupeptin per ml. Debris from cell lysates was pelleted for 15 min at 16,000 ϫ g. Twenty micrograms of protein from each extract was separated in a sodium dodecyl sulfate-15% polyacrylamide gel. Proteins were transferred to Immobilon P (Mil- 
RESULTS

BUR3 is identical to MOT1.
The Bur selection identified mutations in six genes that appear to comprise two phenotypic classes. One class consists of BUR1, BUR2, BUR4, and BUR5, while the other class consists of BUR3 and BUR6. Mutations in BUR3 and BUR6 are similar in that they are the only bur mutations that cause Gal Ϫ and weak Spt Ϫ phenotypes and are also unable to suppress an snf5⌬ allele. Before attempting to clone BUR3 by standard plasmid complementation of the recessive bur3-1 allele, we first tested whether BUR3 might be identical to any previously cloned genes that cause similar mutant phenotypes. The bur3-1 mutation was not complemented by plasmids that contained SIN3, SIN4, GAL11, RPB1, RPB2, or any of the previously characterized SPT genes. In contrast, a MOT1 CEN plasmid complemented all the phenotypes of bur3-1, including the Bur Ϫ , Ts Ϫ , Gal Ϫ , and slowgrowth phenotypes. To determine whether bur3-1 was actually a mutation of MOT1, complementation and linkage tests were performed. The bur3-1 and mot1-1 mutations were unable to complement each other in heterozygous diploids and were tightly linked, displaying no recombination in 20 four-spored tetrads. BUR3 is therefore identical to MOT1, an essential gene previously shown to encode an inhibitor of TBP (3). The bur3-1 allele will hereinafter be referred to as mot1-301.
Molecular cloning and sequence analysis of BUR6. The finding that BUR3 is identical to MOT1 prompted further characterization of BUR6 at the molecular level, since the bur6-1 and mot1-301 mutations cause similar mutant phenotypes. The BUR6 gene was cloned by transforming a bur6-1 strain with a yeast genomic DNA library in a centromeric vector (49) and by screening for plasmids that complemented the bur6-1 Gal Ϫ phenotype. A single plasmid was obtained and designated pGP256. In addition to complementing the Gal Ϫ phenotype of bur6-1, pGP256 also complemented the Bur Ϫ and slow-growth phenotypes (Fig. 1) .
To identify the location of BUR6 within the plasmid insert, the chromosomal region contained in pGP256 was characterized by sequencing the ends of the pGP256 insert. A comparison of this nucleotide sequence with sequences in the GenBank database revealed that pGP256 contained portions of the SPT2 and BEM2 open reading frames on either end. The nucleotide sequence of the SPT2-BEM2 region of chromosome V was kindly provided by F. Dietrich, revealing that in addition to the amino terminus of BEM2 and the carboxy terminus of SPT2, pGP256 also contained a Ty element, a tRNA Arg gene, and five previously unidentified open reading frames (Fig. 2) . A 2.4-kb subclone (pGP258) that contained only one open reading frame and the tRNA Arg gene was able to fully complement all of the phenotypes caused by bur6-1, indicating that BUR6 was contained within that 2.4-kb fragment (Fig. 1) A BLAST comparison of the BUR6 nucleotide sequence with sequences in the current GenBank database revealed that BUR6 encodes a 142-amino-acid protein with significant sequence similarity to histone H2A and other members of the histone fold family of proteins (Fig. 3) . The histone fold is a structural motif of approximately 65 amino acids in length originally identified from crystallographic analysis of the histone octamer (1), but this domain has since been predicted (4) and demonstrated (65) to occur in a number of nonhistone proteins. The histone fold constitutes an interface for specific and direct interactions between two histone fold proteins. For example, the histone fold domains are responsible for extensive direct interactions between histones H2A and H2B, between histones H3 and H4 (1) , between HAP3/CBF-A and HAP5/ CBF-C (53), and between Drosophila TAF II 42 (dTAF II 42) and dTAF II 62 (65) . The score showing highest similarity to BUR6 was that of DRAP1/NC2␣, a human protein recently identified as a transcriptional repressor that inhibits interactions between TBP and the GTFs TFIIA and/or TFIIB in vitro (19, 38) . Inhibition of TBP by DRAP1/NC2␣ occurs through a heterodimeric complex of DRAP1/NC2␣ and Dr1/NC2␤. The similarity between Bur6p and DRAP1/NC2␣ is highly significant (45% identity and 72% similarity over 79 amino acids) and extends slightly beyond the carboxy-terminal end of the histone fold domain. Deletion analysis (described below) demonstrates the importance of the DRAP1/NC2␣-homologous domain for Bur6p function in vivo. Furthermore, recent biochemical studies (17, 18, 31) indicate that Bur6p directly interacts with a yeast Dr1 homolog and that the Bur6p-yDr1 complex represses transcription in vitro. Bur6p thus encodes a yeast homolog of DRAP1/NC2␣. bur6 null phenotype. To determine the effects of a complete loss of BUR6 function, a bur6 null allele was constructed and integrated into the genome of a diploid yeast strain, replacing one of the wild-type BUR6 alleles. When the heterozygous BUR6 ϩ /bur6⌬2::TRP1 diploids were sporulated and the tetrads were dissected, the resulting tetrads produced two healthy colonies and two microcolonies that were easily visible with the naked eye only after 7 to 10 days of growth (Fig. 4) . Although the bur6⌬2::TRP1 cells were viable, their remarkably poor growth and relatively high frequency of reversion prohibited further analysis of the bur6⌬ strains. The growth defect was directly attributable to bur6⌬2::TRP1, since poor growth and the Trp ϩ phenotype cosegregated precisely in more than 100 tetrads. Furthermore, the growth defect can be rescued by transforming the heterozygous diploid strain with a BUR6 ϩ URA3 plasmid prior to sporulation; after tetrad dissection, viable and healthy bur6⌬2::TRP1 colonies were obtained (Fig.  4) and all the Trp ϩ colonies were also Ura ϩ , indicating that the poor growth of the bur6⌬2::TRP1 strain is rescued by a BUR6 ϩ plasmid. Continued viability was dependent upon the URA3 BUR6 ϩ plasmid, since all Trp ϩ colonies were 5-fluoroorotic acid (5-FOA) sensitive. Combined, these results indicate that although BUR6 function is not absolutely required for viability, it is clearly critical for normal cell growth.
BUR6 deletion analysis. To determine whether the histone fold similarity was functionally significant and to delimit the regions of BUR6 that are required for function in vivo, an extensive series of nonoverlapping bur6 deletion alleles was constructed and tested for function in vivo (Fig. 5A) . BUR6 function was assayed in two ways, first, by plasmid complementation of the slow-growth, Bur Ϫ , and Gal Ϫ phenotypes of the chromosomal bur6-1 mutation and second, by testing the phenotypes of the plasmid-borne bur6 deletion alleles in a chromosomal bur6 null background. The results from the deletion analysis are striking; five different alleles that each have 10 amino acids deleted between residues 51 and 100 are completely nonfunctional for BUR6 function by these assays; they do not complement bur6-1 and are inviable in a bur6 null strain. Four other alleles have partial complementing activity; ⌬41-50, in which residues directly amino terminal to the histone fold domain are deleted, and three alleles that, combined, have amino acids 101 through 130 deleted each show reduced complementation of bur6-1 and also have Bur Ϫ and Gal Ϫ phenotypes in a chromosomal bur6 null strain. In contrast, all other deletions within the amino-terminal and carboxy-terminal tails of BUR6 have no detectable effect on BUR6 function. The region of BUR6 that is absolutely essential for function (amino acids 50 through 100) thus corresponds well to the most conserved part of the histone fold, where amino acids 53 to 93 of Bur6p are 66% identical and 83% similar to human DRAP1 (Fig. 3) . To determine whether redundancy within the amino-terminal tail accounts for the lack of phenotype by the N-terminal deletions, the entire N-terminal tail from residues 2 through 40 was deleted, with no apparent effect on BUR6 function. Western analysis (Fig. 5B ) indicated that the nonfunctional alleles produce detectable amounts of the mutant proteins. In fact, the nonfunctional deletion alleles generally produced higher levels of Bur6 protein than functional deletion derivatives, suggesting that BUR6 may be regulated by a negative feedback loop. These results demonstrate the importance of the BUR6 histone fold domain in vivo and suggest that this domain may also be sufficient for function, since the amino-and carboxy-terminal tails of BUR6 appear to be dispensable by these in vivo assays. bur6-1 increases expression of other ⌬UAS reporter genes. Because bur6-1 increased transcription from the suc2⌬uas promoter and caused other mutant phenotypes, it was proposed (47) that Bur6p might function as a repressor of the general transcription machinery. If this is true, then bur6-1 might be expected to increase expression from promoters other than suc2⌬uas, as has previously been shown for the mot1-1 mutation (13) . To test this prediction, the effects of the bur6-1 mutation on expression from the cyc1⌬uas and the ho⌬uas core , and slow-growth phenotypes. ϩϩϩ indicates complete complementation, ϩ indicates weak complementation, and Ϫ indicates lack of complementation. LEU2 CEN plasmids containing the deletion alleles were also transformed into GY568 (bur6⌬2::TRP1 [CEN BUR6
ϩ URA3]) and streaked onto 5-FOA plates to assess the plasmid phenotypes in a bur6⌬ background (right column). (B) Western analysis of bur6 deletion alleles. CEN plasmids containing the deletion alleles shown above the lanes were transformed into GY561 (bur6-1), and extracts prepared from these strains were probed with polyclonal anti-Bur6 antibody (a gift of E. Gadbois and R. Young). The position of the 21-kDa molecular mass marker is shown on the right.
VOL. 17, 1997 BUR6 BOTH ACTIVATES AND REPRESSES IN YEAST 2061
promoters were determined. Plasmids containing cyc1⌬uas-lacZ and ho⌬uas-lacZ were transformed into BUR ϩ and bur6-1 strains, and ␤-galactosidase levels were quantitated. Both reporter plasmids reproducibly directed higher levels of expression of lacZ in the bur6-1 mutant strain relative to that of a BUR ϩ strain ( Fig. 6A and B) , indicating that the effects of bur6-1 are not limited to suc2⌬uas. For the cyc1⌬uas-lacZ plasmid, expression levels were relatively equivalent under both repressing and derepressing conditions for wild-type CYC1 expression, as expected due to the absence of the CYC1 UAS. Similar constitutively increased expression from cyc1⌬uas has been observed in mot1-1, sin4⌬, and gal11⌬ strains and in strains that have been depleted of histone H4 (7, 13, 21, 28) . To determine whether BUR6 has any effect on the intact CYC1 and HO promoters, plasmids that express wild-type CYC1-lacZ (pLG669Z) or HO-lacZ (p1701) were transformed into BUR6 ϩ and bur6-1 strains, and expression of ␤-galactosidase was assayed. bur6-1 caused a slight (less than twofold) reduction of expression of CYC1-lacZ but caused a dramatic reduction of expression of HO-lacZ ( Fig. 6C and D) . Combined with the results described below, this indicates that BUR6 affects expression from some intact promoters and is not limited to ⌬UAS promoters.
BUR6 is required for full induction of GAL1 and GAL10 transcription. Among the unselected phenotypes caused by bur6-1 and mot1-301, the Gal Ϫ phenotype was particularly interesting, because it suggested that some genes involved in galactose metabolism might not be properly induced in these mutant strains. This would be intriguing in light of previous biochemical characterization of Mot1p and DRAP1, since it implies that BUR6 and MOT1 may have positive roles at some promoters in vivo and negative transcriptional roles at other promoters. To investigate this possibility, BUR ϩ , bur6-1, and mot1-301 strains were inoculated into media that contained either raffinose (nonrepressing and noninducing) or galactose (inducing) as the carbon source. RNA was prepared from these cultures at three time points after galactose induction, and Northern blots were used to detect the levels of expression from the GAL1 and GAL10 promoters. Strong and rapid induction of GAL1 and GAL10 was observed in BUR ϩ strains grown in galactose medium, as expected. The level of induction was much lower for both GAL1 and GAL10 (Fig. 7) in the bur6-1 and mot1-301 strains throughout the time course, consistent with their Gal Ϫ phenotype. Expression of the SPT15 gene was unaffected by either mutation and therefore serves as an internal loading control for this experiment. The Gal Ϫ defect is not likely to be due to reduced expression of the Gal4 activator, since overexpression of Gal4p from a 2m plasmid does not suppress the bur6-1 or mot1-301 Gal Ϫ defect. These results indicate that Bur6p and Mot1p are required, either directly or indirectly, for induction of GAL1 and GAL10 mRNAs.
To investigate the cis-acting sequences responsible for the Gal Ϫ defect, a series of promoter fusions was employed.
BUR6
ϩ and bur6-1 strains were first transformed with a plasmid that expresses the intact GAL1-lacZ promoter (pRY131) and with pRY131 deletion derivatives that remove most (p1⌬7) or all (p1⌬1) of the Gal4p binding sites. lacZ expression from pRY131 was greatly reduced in a bur6-1 strain, faithfully reproducing effects observed with the genomic GAL1 gene (Fig. 8) . The p1⌬7 deletion that removes two of the four Gal4p binding sites also exhibits approximately fivefold lower expression in a bur6-1 strain. In contrast, a deletion that removes all of the Gal4p binding sites (p1⌬1) but leaves the GAL1 core promoter intact is unaffected by a bur6-1 mutation.
To investigate whether the Gal Ϫ defect is a property of the FIG. 6 . bur6-1 causes increased expression from two other basal promoters. (A) Yeast strains GY218 (bur6-1) and GY319 (BUR6 ϩ ) were transformed with a cyc1⌬uas plasmid (pLG⌬178). Individual transformants were grown in either SC-Ura plus raffinose (Raff) or SC-Ura plus glucose (Glu). Extracts were prepared, and ␤-galactosidase (␤-gal) activities were quantitated as described previously (39) . Levels from GY218 (bur6-1) are represented by filled boxes, while levels from GY319 (BUR6 ϩ ) are represented by hatched boxes. (B) GY218 (bur6-1) and GY319 (BUR6 ϩ ) were transformed with an ho⌬uas plasmid (M740), grown in SC-Ura medium, and assayed for ␤-galactosidase activity as described for panel A. (C) GY215 (bur6-1) and GY315 (BUR6 ϩ ) were transformed with a CYC1-lacZ plasmid (pLG669Z), grown in SC-Ura plus raffinose medium, and assayed for ␤-galactosidase activity as described for panel A. (D) GY215 (bur6-1) and GY315 (BUR6 ϩ ) were transformed with an HO-lacZ plasmid (p1701), grown in SC-Ura medium, and assayed for ␤-galactosidase activity as described for panel A. ␤-Galactosidase levels are the means from at least three experiments using independent transformants, with standard errors (T bars) of Ͻ20%.
FIG. 7.
bur6-1 and mot1-301 cause reduced levels of GAL1 and GAL10 mRNA induction. Yeast strains GY315 (BUR6 ϩ ), GY215 (bur6-1), and GY236 (mot1-301) were grown in YP plus raffinose (noninducing and nonrepressing) medium, harvested, and resuspended in YP plus galactose (inducing) liquid medium. RNAs were isolated from these strains at 0, 1, 2, and 4 h after galactose induction. Three micrograms of total RNA was separated in a 1% formaldehyde agarose gel, transferred to a GeneScreen filter, and hybridized with a GAL1-and GAL10-specific probe. The filters were subsequently stripped and reprobed with an SPT15-specific probe as a loading control. The positions of the GAL1, GAL10, and SPT15 mRNAs are indicated.
UAS, plasmids that contain either the intact GAL10 UAS (pLGSD5) or duplicated Gal4p binding sites (pSV14) fused to the UAS-less CYC1p-lacZ reporter were transformed into BUR6 ϩ and bur6-1 strains and ␤-galactosidase levels were quantitated 1.5 h after induction by galactose. Both pLGSD5 and pSV14 directed high levels of ␤-galactosidase in a BUR ϩ strain upon galactose induction but were defective for induction in a bur6-1 strain (Fig. 8) . In contrast, ␤-galactosidase expression from the UAS-less CYC1p-lacZ plasmid was slightly increased in the bur6-1 strain, as might be expected. Combined, these results indicate that BUR6 affects other genes besides SUC2, affects some intact wild-type promoters, and has both positive and negative roles on transcription in vivo.
DISCUSSION
The Bur selection was designed to identify components or regulators of the basal transcription machinery. The data presented here, combined with our previous results, indicate that this approach has been successful. The bur mutations were previously grouped into two phenotypic classes, with the implication that these phenotypic classes are due to mutations that suppress suc2⌬uas by biochemically distinct mechanisms. The previously reported cloning of BUR1, BUR4, and BUR5 (47), combined with the results presented here, supports this hypothesis.
The bur mutations appear to comprise two phenotypic classes: one class of BUR genes includes BUR1, BUR2, BUR4, and BUR5, while the other class consists of BUR3 and BUR6. Because BUR5 is identical to HHT1, which encodes histone H3, mutations in the first class were proposed to suppress suc2⌬uas by interfering with nucleosome repression of the GTFs (47) . The identification of BUR4 as SPT21 further supports this classification, as SPT21 has a role in both positively and negatively modulating transcription of a large number of differentially regulated genes, possibly by affecting the levels of histone mRNA (14, 52) . Finally, the majority of mutations identified by the Bur selection were in genes that encode histones H2A and H2B and in other SPT genes that are proposed to have roles in chromatin repression (5, 62) . The specific roles of BUR2, which encodes a novel protein (46) , and BUR1 (also called SGV1), which encodes a putative protein kinase (26) , remain unknown but are currently under investigation.
The second class of BUR genes, consisting of BUR3 and BUR6, are the subject of this report. These genes were of particular interest because of their proposed roles as chromatin-independent repressors of basal transcription. The identification of BUR3 as MOT1 lends strong support to this model, since MOT1 encodes an ATP-dependent inhibitor of TBP (3). The Mot1 protein specifically displaces TBP from the TATA box in the presence of hydrolyzable forms of ATP but has no effect on two other site-specific DNA-binding proteins tested. This biochemical characterization of Mot1p is consistent with the phenotype of partial loss-of-function mot1 mutations, which increase transcription from ⌬UAS promoters in vivo (13) . The identification of BUR3 as MOT1 was particularly intriguing in light of the phenotypic similarities between the bur3 and bur6 mutations, as these results suggested that BUR6 functions in a manner similar to that of MOT1 in vivo.
The molecular cloning of BUR6 revealed a region of significant amino acid similarity to the histone fold family of proteins. This similarity at first suggested that Bur6p might function via nucleosome-mediated repression of the general factors; however, certain results favor a nucleosome-independent model. First, the bur6-1 mutation causes a subset of phenotypes that are more similar to those caused by the bur3-1 (mot1) mutation than to those conferred by the histone class of bur mutations. Second, the similarity between Bur6p and histone H2A is limited strictly to the histone fold domain; there is no similarity to histones outside the histone fold domain, and whereas the core histones are highly positively charged in both the amino-and carboxy-terminal tails, Bur6p is negatively charged outside of the histone fold domain. Finally, the sequence of Bur6p is most similar to a recently identified human protein known as DRAP1 (38) or NC2␣ (19) , which functions as a repressor of TBP in vitro. Deletion analysis (Fig. 5) indicates that the region of BUR6 that is required in vivo correlates well with the extent of the DRAP1/NC2␣-homologous region, while nonessential amino-terminal and carboxy-terminal regions are not conserved in distantly related organisms. Further support of the proposal that BUR6 functions as a DRAP1/ NC2␣ homolog is provided by the yeast genome sequencing project: a yeast Dr1/NC2␤ homolog has been identified on chromosome IV, and BUR6 is the only yeast gene similar to the Dr1 binding partner DRAP1/NC2␣. Finally, Bur6p copurifies FIG. 8 . A bur6 mutation reduces expression from UAS GAL -lacZ and HO-lacZ reporter plasmids. (A) Plasmid pRY131 (GAL1-lacZ) and two deletion derivatives (p1⌬7 and p1⌬1) were transformed into GY215 (bur6-1) and GY315 (BUR ϩ ), and expression of ␤-galactosidase was assayed after 1.5 h of induction by galactose. The locations of the four Gal4p binding sites within the UAS are depicted above the UAS. Regions deleted in p1⌬7 and p1⌬1 are depicted as filled boxes. The figure is not drawn to scale. (B) Plasmids that contain the UAS-less CYC1-lacZ reporter (pLG670Z), CYC1-lacZ under the control of UAS GAL1 (pLGSD5), or two Gal4p 17-mer binding sites (pSV14) were transformed into GY215 (bur6-1) and GY315 (BUR with yeast Dr1 over several column chromatography steps and binds directly to yeast Dr1 (17, 18, 31) . Bur6p therefore also displays the biochemical characteristics expected of a DRAP1/ NC2␣ homolog.
Although BUR6 was initially identified by a selection for mutations that affect the suc2⌬uas promoter, its effects are clearly not limited to SUC2 or to basal transcription. The bur6-1 mutation causes increased transcription from three ⌬UAS promoters tested (SUC2, HO, and CYC1) , although the effects are rather modest when compared to full levels of induction. Similar partial increase in expression was observed in a series of studies examining the effects of histone H4 depletion in yeast (15, 21) and in strains containing mutations in MOT1 (13), SIN4 (7, 28) , SPT5 (56), SPT6 (43, 57) , SPT16/ CDC68 (36) , and GAL11 (7). The relatively modest effects of the bur6-1 mutation may also be due to the fact that only a single bur6 allele was isolated and that a bur6 null allele causes extremely slow growth, so only partial loss-of-function alleles were likely to be isolated. Finally, other repressors, such as Mot1p (13) , the Spt proteins (62), the Not proteins (11) , and nucleosomes, are still likely to be repressing basal transcription in the bur6 mutant cells, thereby preventing complete derepression.
In addition to increasing transcription from promoters that have had their UAS deleted, the bur6-1 and mot1-301 mutations also reduce activated levels of transcription from the wild-type GAL1 and GAL10 promoters. The reduced levels of GAL1 and GAL10 mRNAs are not simply due to reduced activity of the Gal4p activator, since transformation of a bur6-1 strain with a plasmid that overexpresses Gal4p does not revert the Gal Ϫ phenotype (46) . The activation defect is not likely to be restricted to galactose-induced genes, since an HO-lacZ reporter was also defective for expression in a bur6-1 strain. BUR6 is not required for activation by all UAS elements, however, as expression of the wild-type SPT15 and CYC1 genes was unaffected in bur6-1 strains. Results presented here indicate that the GAL10 activation defect is due to an inability of either the intact GAL10 UAS or duplicated Gal4p binding sites to function as a UAS, since either of these elements fused to the CYC1 promoter induces strong galactose-dependent expression in a BUR ϩ strain but not in a bur6-1 background. The reduction of GAL1 and GAL10 transcript levels in bur6-1 and mot1-301 strains was surprising, since all previously published in vitro characterization of Mot1 and DRAP1/NC2␣ indicated that these proteins function as repressors, which was consistent with the existing genetic characterization of mot1 mutations. However, the results presented here suggest that Bur6p and Mot1p may have dual functions in vivo, both as activators and as repressors. Recent results from other labs are also consistent with dual activator and repressor roles for Mot1p in vivo (10, 35) . Proteins that have such dual activating and repressing roles are not uncommon. For example, mutations in the histone genes, SPT21, RPD3, MCM1, and SIN3 all cause increased transcription at some promoters but decreased transcription at others (16, 29, 30, 41, (59) (60) (61) . How might such dual effects be explained? One model would be that Bur6p and Mot1p may each be associated with two different complexes, one of which activates and the other of which represses transcription. Such a direct dual role has been demonstrated for the yeast Mcm1 protein and a number of mammalian transcription factors. Alternatively, it is possible that one function is direct while the other is indirect. For example, Bur6p may have direct effects only as a repressor but may phenotypically appear to be an activator of GAL genes if it represses a GALspecific repressor. Future experiments will be required to address the specific roles of BUR6 in repression and/or activation.
The existence of systems for global repression of transcription that is dependent upon proteins such as Bur6p, Mot1p, and histones leads to the interesting question of how the cell overcomes this repression machinery to allow transcriptional activation under the appropriate conditions. It appears that the SNF-SWI complex plays an important role in overcoming nucleosomal repression, but it remains to be seen whether SNF-SWI or other activities that are thought to function through chromatin remodeling also play a role in Mot1p-and Bur6p-dependent repression. The inability of bur6 and mot1 mutations to suppress snf5⌬ suggests that SNF-SWI does not overcome repression by Mot1p or Bur6p. Recent studies suggest that TFIIA may play a role in stabilizing TBP from the displacement activity of Mot1p, but it remains to be seen whether TFIIA performs the same role in vivo. It seems likely that at least part of the function of activator proteins is to overcome the effects of repressors such as Bur6p, either directly or through coactivator intermediates. Detecting these proposed activator-repressor interactions and testing their possible functional significance in vivo should be possible in an organism, such as yeast, that allows sophisticated genetic analysis.
The combination of biochemical and genetic analysis of proteins, such as MOT1 and BUR6, that modulate the activities of the GTFs will contribute to a more detailed understanding of the intricacies of transcriptional control in all eukaryotic cells, including the interplay between proteins that activate and repress transcription.
